skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Wiley-Blackwell Full Collection 2009 remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Impact of baseline characteristics and beta‐cell function on the efficacy and safety of subcutaneous once‐weekly semaglutide: A patient‐level, pooled analysis of the SUSTAIN 1‐5 trials
Impact of baseline characteristics and beta‐cell function on the efficacy and safety of subcutaneous once‐weekly semaglutide: A patient‐level, pooled analysis of the SUSTAIN 1‐5 trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of baseline characteristics and beta‐cell function on the efficacy and safety of subcutaneous once‐weekly semaglutide: A patient‐level, pooled analysis of the SUSTAIN 1‐5 trials

Aroda, Vanita R. ; Capehorn, Matthew S. ; Chaykin, Louis ; Frias, Juan P. ; Lausvig, Nanna L. ; Macura, Stanislava ; Lüdemann, Jörg ; Madsbad, Sten ; Rosenstock, Julio ; Tabak, Omur ; Tadayon, Sayeh ; Bain, Stephen C.

Diabetes, obesity & metabolism, 2020-03, Vol.22 (3), p.303-314

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
2
A microbiome‐targeting fibre‐enriched nutritional formula is well tolerated and improves quality of life and haemoglobin A1c in type 2 diabetes: A double‐blind, randomized, placebo‐controlled trial
A microbiome‐targeting fibre‐enriched nutritional formula is well tolerated and improves quality of life and haemoglobin A1c in type 2 diabetes: A double‐blind, randomized, placebo‐controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

A microbiome‐targeting fibre‐enriched nutritional formula is well tolerated and improves quality of life and haemoglobin A1c in type 2 diabetes: A double‐blind, randomized, placebo‐controlled trial

Frias, Juan P. ; Lee, Martin L. ; Carter, Matthew M. ; Ebel, Emily R. ; Lai, Ren‐Hau ; Rikse, Lars ; Washington, Marc E. ; Sonnenburg, Justin L. ; Damman, Christopher J.

Diabetes, obesity & metabolism, 2023-05, Vol.25 (5), p.1203-1212

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
3
Cardiovascular efficacy and safety of antidiabetic agents: A network meta‐analysis of randomized controlled trials
Cardiovascular efficacy and safety of antidiabetic agents: A network meta‐analysis of randomized controlled trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cardiovascular efficacy and safety of antidiabetic agents: A network meta‐analysis of randomized controlled trials

Sohn, Minji ; Frias, Juan P. ; Lim, Soo

Diabetes, obesity & metabolism, 2023-12, Vol.25 (12), p.3560-3577

Oxford: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
4
Methyl aminolevulinate photodynamic therapy for onychomycosis: a multicentre, randomized, controlled clinical trial
Methyl aminolevulinate photodynamic therapy for onychomycosis: a multicentre, randomized, controlled clinical trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Methyl aminolevulinate photodynamic therapy for onychomycosis: a multicentre, randomized, controlled clinical trial

Gilaberte, Y. ; Robres, M.P. ; Frías, M.P. ; García‐Doval, I. ; Rezusta, A. ; Aspiroz, C.

Journal of the European Academy of Dermatology and Venereology, 2017-02, Vol.31 (2), p.347-354 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
5
Tolerability, safety and pharmacodynamics of oral, small‐molecule glucagon‐like peptide‐1 receptor agonist danuglipron for type 2 diabetes: A 12‐week, randomized, placebo‐controlled, Phase 2 study comparing different dose‐escalation schemes
Tolerability, safety and pharmacodynamics of oral, small‐molecule glucagon‐like peptide‐1 receptor agonist danuglipron for type 2 diabetes: A 12‐week, randomized, placebo‐controlled, Phase 2 study comparing different dose‐escalation schemes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tolerability, safety and pharmacodynamics of oral, small‐molecule glucagon‐like peptide‐1 receptor agonist danuglipron for type 2 diabetes: A 12‐week, randomized, placebo‐controlled, Phase 2 study comparing different dose‐escalation schemes

Saxena, Aditi R. ; Frias, Juan P. ; Gorman, Donal N. ; Lopez, Rene N. ; Andrawis, Nabil ; Tsamandouras, Nikolaos ; Birnbaum, Morris J.

Diabetes, obesity & metabolism, 2023-10, Vol.25 (10), p.2805-2814

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
6
Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION‐7 randomized study
Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION‐7 randomized study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION‐7 randomized study

Guja, Cristian ; Frías, Juan P. ; Somogyi, Aniko ; Jabbour, Serge ; Wang, Hui ; Hardy, Elise ; Rosenstock, Julio

Diabetes, obesity & metabolism, 2018-07, Vol.20 (7), p.1602-1614

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
7
A 96‐week, double‐blind, randomized controlled trial comparing bexagliflozin to glimepiride as an adjunct to metformin for the treatment of type 2 diabetes in adults
A 96‐week, double‐blind, randomized controlled trial comparing bexagliflozin to glimepiride as an adjunct to metformin for the treatment of type 2 diabetes in adults
Material Type:
Artigo 		Adicionar ao Meu Espaço

A 96‐week, double‐blind, randomized controlled trial comparing bexagliflozin to glimepiride as an adjunct to metformin for the treatment of type 2 diabetes in adults

Halvorsen, Yuan‐Di ; Lock, John Paul ; Frias, Juan P. ; Tinahones, Francisco José ; Dahl, Dominik ; Conery, Annie L. ; Freeman, Mason W.

Diabetes, obesity & metabolism, 2023-01, Vol.25 (1), p.293-301

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
8
iGlarLixi versus basal plus Rapid‐Acting insulin in adults with type 2 diabetes advancing from basal insulin therapy: The SoliSimplify Real‐World study
iGlarLixi versus basal plus Rapid‐Acting insulin in adults with type 2 diabetes advancing from basal insulin therapy: The SoliSimplify Real‐World study
Material Type:
Artigo 		Adicionar ao Meu Espaço

iGlarLixi versus basal plus Rapid‐Acting insulin in adults with type 2 diabetes advancing from basal insulin therapy: The SoliSimplify Real‐World study

McCrimmon, Rory J. ; Cheng, Alice Y.Y. ; Galstyan, Gagik ; Djaballah, Khier ; Li, Xuan ; Coudert, Mathieu ; Frias, Juan P.

Diabetes, obesity & metabolism, 2023-01, Vol.25 (1), p.68-77

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
9
Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD‐11
Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD‐11
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD‐11

Bonora, Enzo ; Frias, Juan P. ; Tinahones, Francisco J. ; Van, Joanna ; Malik, Raleigh E. ; Yu, Zhuoxin ; Mody, Reema ; Bethel, Angelyn ; Kwan, Anita Y. M. ; Cox, David A.

Diabetes, obesity & metabolism, 2021-10, Vol.23 (10), p.2242-2250

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
10
Clinical trial: Effects of pegozafermin on the liver and on metabolic comorbidities in subjects with biopsy‐confirmed nonalcoholic steatohepatitis
Clinical trial: Effects of pegozafermin on the liver and on metabolic comorbidities in subjects with biopsy‐confirmed nonalcoholic steatohepatitis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical trial: Effects of pegozafermin on the liver and on metabolic comorbidities in subjects with biopsy‐confirmed nonalcoholic steatohepatitis

Alkhouri, Naim ; Lazas, Donald ; Loomba, Rohit ; Frias, Juan P. ; Feng, Shibao ; Tseng, Leo ; Balic, Kemal ; Agollah, Germaine D. ; Kwan, Tinna ; Iyer, Janani S. ; Morrow, Linda ; Mansbach, Hank ; Margalit, Maya ; Harrison, Stephen A.

Alimentary pharmacology & therapeutics, 2023-11, Vol.58 (10), p.1005-1015 [Periódico revisado por pares]

Chichester: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (55)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (76)
  2. Reports  (2)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1998  (6)
  2. 1998Até2004  (12)
  3. 2005Até2009  (20)
  4. 2010Até2018  (16)
  5. Após 2018  (25)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.